Your browser doesn't support javascript.
loading
P80 Natural Essence Exerts Efficient Anti-HIV-1- as Well as Adjuvant Effects in DCs.
Zaderer, Viktoria; Posch, Wilfried; Gstir, Ronald; Filipek, Przemyslaw A; Bonn, Günther K; Aramwit, Pornanong; Huber, Lukas A; Wilflingseder, Doris.
Affiliation
  • Zaderer V; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Posch W; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Gstir R; ADSI-Austrian Drug Screening Institute GmbH, 6020 Innsbruck, Austria.
  • Filipek PA; ADSI-Austrian Drug Screening Institute GmbH, 6020 Innsbruck, Austria.
  • Bonn GK; ADSI-Austrian Drug Screening Institute GmbH, 6020 Innsbruck, Austria.
  • Aramwit P; Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences and Center of Excellence in Bioactive Resources for Innovative Clinical Applications, Chulalongkorn University, Bangkok 10330, Thailand.
  • Huber LA; ADSI-Austrian Drug Screening Institute GmbH, 6020 Innsbruck, Austria.
  • Wilflingseder D; Institute of Cell Biology, Biocenter Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Vaccines (Basel) ; 9(9)2021 Aug 31.
Article de En | MEDLINE | ID: mdl-34579213
ABSTRACT
Dendritic cells (DCs), as well as complement, play a major role during human immunodeficiency virus 1 (HIV-1) entry and infection at mucosal sites. Together, DCs and complement are key points for understanding host defence against HIV-1 infection and for studying the impact of new drugs on the regulation of innate host-pathogen interactions and adaptive immunity. For this, we evaluated the antiviral effect of the P80 natural essence (Longan extract) on interactions of non- and complement-opsonized HIV-1 with DCs. In viability assays, we first illustrated the effects of P80 natural essence on DC function. We found that P80 concentrations above 1.5% caused increased cell death, while at concentrations between 0.5% and 1% the compound exerted efficient antiviral effects in DCs and illustrated an adjuvant effect regarding DC activation. DC maturation, as well as co-stimulatory capacity, were significantly improved by P80 natural essence via p38 MAPK phosphorylation in presence of the viral challenge independent of the opsonization pattern. These findings might be exploited for future therapeutic options to target DC subsets directly at mucosal sites by P80 natural essence and to block entry of both, non- and complement-opsonized HIV-1.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Vaccines (Basel) Année: 2021 Type de document: Article Pays d'affiliation: Autriche

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Vaccines (Basel) Année: 2021 Type de document: Article Pays d'affiliation: Autriche
...